基本情報
- 標準SMILES
Cc1ncc[nH]1- InChIKey
LXBGSDVWAMZHDD-UHFFFAOYSA-N- 分子式
- C4H6N2
- 平均分子量
- 82.1 g/mol
- 単同位体質量
- 82.05309819
概要
2-Methylimidazole can cause cancer according to California Labor Code.
名称と識別子
- 優先名称
- 2-Methylimidazole
- IUPAC
- 2-methyl-1H-imidazole
- 現地名
- 2-メチルイミダゾール
- 英語名
- 2-Methylimidazole
- 分子式
- C4H6N2
- 分子量
- 82.1
名称と別名
名称をさらに表示
データベース識別子
- CAS
693-98-1- PubChem CID
- 12749
- DTXSID
DTXSID4022107- ChEMBL
CHEMBL293391- UNII
- T0049Z45LZ
- EC Number
- 211-765-7
- Nikkaji
- J49.341D
物性
構造計算による物性
- XLogP
- 0.2
- 極性表面積
- 28.7 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 1
- 回転可能結合数
- 0
- 重原子数
- 6
- 形式電荷
- 0
- 複雑度
- 44.8
実験および物理化学的性質
LogP
log Kow = 0.24
0.24
Physical Description
Other Solid; Dry Powder; Large Crystals; Liquid
Solid; [HSDB] Colorless solid; [NTP] Crystalline solid; [Alfa Aesar MSDS]
物理化学的性質
- 融点
- 142 · 142-143 °C (lit.)
- 沸点
- 267 · 267-268 °C (lit.)
- 比重(密度)
- 1.05 · 1.0500 (rough estimate)
- 蒸気圧
- 1 mm · <1 mm Hg ( 0 °C)
- 屈折率
- 1.497 · 1.4970 (estimate)
- 闪点
- 155 °C · 155 °C
- 貯蔵温度
- 2 · 2-8°C
- 溶解性
- 780 g/リットル · 780g/リットル
- 酸解離定数(Pka)
- 14.44 · 14.44±0.10(Predicted)
- 外見
- 結晶性粉末
- 色
- 白色~淡黄色
- PH
- 10.5 · 10.5-11.5 (100g/l, H2O, 20℃)
- 水溶解度
- 水およびエタノールに可溶。
- BRN
- 1368 · 1368
- Henry's Law Constant
- 8.1 · 8.1×102 mol/(m3Pa) at 25℃, Du et al. (2017)
- InChI
- 1S/C4H6N2/c1-4-5-2-3-6-4/h2-3H,1H3,(H,5,6)
- InChIKey
- LXBGSDVWAMZHDD-UHFFFAOYSA-N
- SMILES
- Cc1ncc[nH]1
- LogP
- 0.22 at · 0.22 at 25℃
- CAS データベース
- 693 · 693-98-1(CAS DataBase Reference)
- NISTの化学物質情報
- 1 H-Imidazole, · 1H-Imidazole, 2-methyl-(693-98-1)
- EPAの化学物質情報
- 2 · 2-Methylimidazole (693-98-1)
化学的性質
化学的特性2-Methylimidazole is a white to light yellow crystalline powder with an amine-like odor. It is highly soluble in polar organic solvents. Insoluble in ether and cold benzene, easily soluble in water, alcohols and ketones. Irritating to skin and mucous membranes. Mice orally LD50 1400mg/kg.
化学的特性The 2-methylimidazole molecule is approximately planar, and the maximum deviation of all non-H atoms from the plane of the least squares imidazole is 0.006(2). N–H··· N hydrogen bonds link molecules together to form infinite chains of hydrogen bond pattern C(4). The crystal of 2-methylimidazole is in orthorhombic crystal system with space group P212121 (Z = 4), lattice parameters: a = 5.9957(12) , b = 8.1574(16) and c = 9.7010(19) , V = 474.47(16) [1].
安全と法規制
GHS分類
GHS Classification
Danger
H360Df: May damage the unborn child; Suspected of damaging fertility [Danger Reproductive toxicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
This chemical does not meet GHS hazard criteria for 8.4% (64 of 758) of reports.
Danger
H302 (81.9%): Harmful if swallowed [Warning Acute toxicity, oral]
危険有害性情報
Regulatory Information
Chemical: 1H-Imidazole, 2-methyl-
Hazard Traits - Carcinogenicity; Reproductive Toxicity
1H-Imidazole, 2-methyl- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 1H-Imidazole, 2-methyl- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
Status: Active Update: 31-05-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/5866
Substance: 2-methylimidazole
2-Methylimidazole: Does not have an individual approval but may be used under an appropriate group standard
Hazards Summary
Causes neurological effects including convulsions and tremors in livestock and experimental animals; Changes in thyroid hormone concentrations, anemia, and testicular degeneration observed in studies of rodents; [NTP] Causes burns; Inhalation may cause corrosive injuries to upper respiratory tract and lungs; Toxic by ingestion; [Alfa Aesar MSDS] See 4-Methylimidazole.
Special Reports
Department of Health & Human Services/National Institute of Environmental Health Sciences, National Toxicology Program; Toxicology and Carcinogenesis Studies of 2-Methylimidazole (CAS No. 693-98-1) in F344/N Rats and B6C3F1 Mice (Feed Studies), NTP TR 516 (December 2004).
Hazard Classes and Categories
Acute Tox. 4 (81.9%)
Acute toxicity (ingestion) - category 4
Acute toxicity (Oral) - Category 4
Reproductive toxicity - Category 1B
Repr. 1B
安全と保護具
Fire Fighting Procedures
Suitable extinguishing media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters: Wear self contained breathing apparatus for fire fighting if necessary.
Cleanup Methods
SRP: Wastewater from contaminant suppression, cleaning of protective clothing/equipment, or contaminated sites should be contained and evaluated for subject chemical or decomposition product concentrations. Concentrations shall be lower than applicable environmental discharge or disposal criteria. Alternatively, pretreatment and/or discharge to a POTW is acceptable only after review by the governing authority. Due consideration shall be given to remediation worker exposure (inhalation, dermal and ingestion) as well as fate during treatment, transfer and disposal. If it is not practicable to manage the chemical in this fashion, it must meet Hazardous Material Criteria for disposal.
Personal precautions: Use personal protective equipment. Avoid dust formation. Avoid breathing dust. Ensure adequate ventilation. Evacuate personnel to safe areas.
Environmental precautions: Do not let product enter drains.
Methods for cleaning up: Pick up and arrange disposal without creating dust. Keep in suitable, closed containers for disposal.
Disposal Methods
SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.
Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Observe all federal, state, and local environmental regulations. Contact a licensed professional waste disposal service to dispose of this material.
Preventive Measures
Handling: Avoid formation of dust and aerosols.
In case of skin contact: Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Consult a physician.
In case of eye contact: Continue rinsing eyes during transport to hospital. Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
Hygiene measures: Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
Personal Protective Equipment (PPE)
Respiratory protection: Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Hand protection: Handle with gloves.
Eye protection: Safety glasses.
Skin and body protection: Choose body protection according to the amount and concentration of the dangerous substance at the work place.
Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire protection.
毒性情報
Ecotoxicity Values
LC50; Species: Pimephales promelas (Fathead minnow, age 30 days, mean length 22.8 mm, mean weight 0.206 g); Conditions: flow through, 24.5 °C, pH 7.68, hardness 44.4 mg/L CaCO3, alkalinity 47.5 mg/L CaCO3, dissolved oxygen 6.0 mg/L; Concentration: 286 mg/L for 96 hr (95% confidence limit: 267-307 mg/L) /99% purity/
Environmental Fate
TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 33(SRC), determined from a log Kow of 0.24(2) and a structure estimation method(3), indicates that 2-methylimidazole is expected to have very high mobility in soil(SRC). The pKa of 2-methylimidazole is 7.86(4), indicating that this compound will partially exist in cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(5). Volatilization of 2-methylimidazole from moist soil surfaces may be an important fate process(SRC) given an estimated Henry's Law constant of 4.1X10-6 atm-cu m/mole(SRC), using a fragment constant estimation method(6). However, volatilization from moist soil may be attenuated because the compound exists partially as a cation and cations do not volatilize. 2-Methylimidazole is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 6.9X10-4 mm Hg at 25 °C(SRC), determined from a fragment constant method(7). Utilizing the Japanese MITI test, 1% of the Theoretical BOD was reached in four weeks(8) indicating that biodegradation is not an important environmental fate process in soil(SRC).
AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 33(SRC), determined from a log Kow of 0.24(2) and a structure estimation method(3), indicates that 2-methylimidazole is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces may be expected(4) based upon an estimated Henry's Law constant of 4.1X10-6 atm-cu m/mole(SRC), developed using a fragment constant estimation method(5). Using this Henry's Law constant and an estimation method(4), volatilization half-lives for a model river and model lake are 190 hours and 62 days, respectively(SRC). According to a classification scheme(6), an estimated BCF of 3.2(SRC), from its log Kow(2) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Utilizing the Japanese MITI test, 1% of the Theoretical BOD was reached in four weeks(8) indicating that biodegradation is not an important environmental fate process in water(SRC).
ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), 2-methylimidazole, which has an estimated vapor pressure of 6.9X10-4 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase 2-methylimidazole is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 4.1 hours(SRC), calculated from its rate constant of 9.4X10-11 cu cm/molecule-sec at 25 °C(3) that was derived using a structure estimation method(3). 2-Methylimidazole does not contain chromophores that absorb at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).
Soil Adsorption/Mobility
The Koc of 2-methylimidazole is estimated as 33(SRC), using a log Kow of 0.24(1) and a structure estimation method(2). According to a classification scheme(3), this estimated Koc value suggests that 2-methylimidazole is expected to have very high mobility in soil. The pKa of 2-methylimidazole is 7.86(4), indicating that this compound will partially exist in cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(5).
Human Toxicity Excerpts
/SIGNS AND SYMPTOMS/ May be harmful if inhaled. Material is extremely destructive to the tissue of the mucous membranes and upper respiratory tract. May be harmful if absorbed through skin. Causes skin burns. Causes eye burns. May be harmful if swallowed. Causes burns.
Artificial Pollution Sources
2-Methylimidazole's production and use in the manufacture of pharmaceuticals, photographic and photothermographic chemicals, dyes, pigments, agricultural chemicals and rubber(1) may result in its release to the environment through various waste streams(SRC).
Carcinogen Classification
2-Methylimidazole
Group 2B: Possibly carcinogenic to humans
Volume 101: (2012) Some Chemicals Present in Industrial and Consumer Products, Food and Drinking-water
2013
2011
2-Methylimidazole
Environmental Bioconcentration
An estimated BCF of 3.2 was calculated in fish for 2-methylimidazole(SRC), using a log Kow of 0.24(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC), provided the compound is not metabolized by the organism(SRC).
Volatilization from Water/Soil
The Henry's Law constant for 2-methylimidazole is estimated as 4.4X10-6 atm-cu m/mole(SRC) using a fragment constant estimation method(1). This Henry's Law constant indicates that 2-methylimidazole may be expected to volatilize from water surfaces(2). Based on this Henry's Law constant, the volatilization half-life from a model river (1 m deep, flowing 1 m/sec, wind velocity of 3 m/sec)(2) is estimated as 190 hours(SRC). The volatilization half-life from a model lake (1 m deep, flowing 0.05 m/sec, wind velocity of 0.5 m/sec)(2) is estimated as 62 days(SRC). 2-Methylimidazole's Henry's Law constant indicates that volatilization from moist soil surfaces may occur(SRC). 2-Methylimidazole is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 6.9X10-4 mm Hg(SRC), determined from a fragment constant method(3).
Non-Human Toxicity Excerpts
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ ... Groups of five male and five female Fischer rats and B6C3F1 mice were administered 2-methylimidazole (2MI) by dosed feed at 0, 1,200, 3,300, or 10,000 ppm ... for 15 days, and groups of 10 male and 10 female Fischer rats and B6C3F1 mice were administered 2MI ... at 0, 625, 1,250, 2,500, 5,000 or 10,000 ppm for 14 weeks. In the 15-day studies, 2MI induced thyroid follicular-cell hyperplasia and pituitary pars-distalis hypertrophy in rats and thyroid follicular-cell hypertrophy and spleen hematopoietic-cell proliferation in mice ... In the 14-week studies, 2MI increased concentrations of thyroid-stimulating hormone (TSH) and decreased those of thyroxine (T(4)) and triiodothyroxine (T(3)) in male and female rats according to the dosage. Incidences of diffuse follicular-cell hyperplasia of the thyroid gland increased significantly in male rats exposed to 1,250 ppm or greater and female rats exposed to 2,500 ppm or greater. Thyroid follicular-cell adenoma was diagnosed in two males in the 10,000-ppm group. A dose-related anemia occurred in female rats. In mice, follicular-cell hypertrophy of the thyroid gland, anemia, splenic hematopoietic-cell proliferation, and hemosiderin in kidney tubules appeared ...
/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Groups of male and female Fischer 344/N rats were fed diets containing 0, 300, 1,000, or 3,000 ppm (males) or 0, 1,000, 2,500, or 5,000 ppm (females) 2-methylimidazole (2MI) for 106 weeks and groups of male and female B6C3F1 mice were fed 0, 625, 1,250, or 2,500 ppm 2MI for 105 weeks. Animals in each group were sacrificed at 8 days, 14 weeks, and 6 months for determinations of serum thyroid hormone and liver enzyme levels and histopathological examinations and at 2 years for evaluations of neoplastic lesions. In rats, 2MI administration reduced serum thyroxine and triiodothyronine and increased thyroid stimulating hormone levels. 2MI administration also increased total hepatic UDP-glucuronosyltransferase levels. At 2 years, the incidences of thyroid follicular cell hyperplasia, adenoma or carcinoma (combined), as well as follicular mineralization were increased. The incidences of hepatocellular adenoma or carcinoma (combined) in the two highest dose groups of males and females were also increased. The incidences of mixed cell focus in males and females were also significantly increased. In mice, the incidences of thyroid follicular cell hypertrophy and hyperplasia were significantly increased in the high dose males and females. The incidence of thyroid follicular cell adenoma in the 2,500 ppm males was significantly greater than that in the control group. The incidences of hepatocellular adenoma or carcinoma (combined) were significantly increased in all exposed groups of males and in the 2,500 ppm females. Significant increases in incidences were also observed in spleen hematopoietic cell proliferation in both sexes and bone marrow hyperplasia, chronic active inflammation of the epididymis, sperm granuloma, and germinal epithelial atrophy of the testis in males. Under these experimental conditions, carcinogenic activity of 2MI was demonstrated in male and female rats and mice.
/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Two-year mouse and rat bioassay studies of 2-methylimidazole (2-MI) conducted by the National Toxicology Program revealed that epididymal sperm granuloma(SG)s occurred only in male B6C3F1 mice in a dose-related manner. The present study characterized 2-MI-induced SGs in these epididymides. Groups of 50 male B6C3F1 mice were fed diets containing 0, 625, 1250, or 2500 ppm 2-MI for 105 weeks; the doses were equivalent to average daily doses of approximately 13, 40, or 130 mg/kg. Testes and epididymides were histopathologically reexamined. 2-Methylimidazole increased the incidence of epididymal SGs (0%, 0%, 6%, 12%, respectively). Histologically, most of the SGs exhibited rupture of epididymal ducts with focal aggregations of macrophages in interstitia. Lesions occurred in the proximal caput of the epididymis and/or efferent ducts, not in the corpus and cauda. In the testis, incidences of germinal epithelial atrophy (GEA) increased dose-relatedly (2%, 8%, 16%, 28%, respectively). All mice with epididymal SG developed testicular GEA. The grading scores of testicular GEA tended to be more severe in mice with SGs than those without. No epididymal SG or testicular GEA was observed in 6-month-interim-sacrificed mice. The results imply that 2-year treatment of B6C3F1 mice with 2-MI can induce epididymal SGs, primarily followed by more severe testicular GEA. The potential mechanism of SG induction by 2-MI is discussed.
Environmental Abiotic Degradation
The rate constant for the vapor-phase reaction of 2-methylimidazole with photochemically-produced hydroxyl radicals has been estimated as 9.4X10-11 cu cm/molecule-sec at 25 °C(SRC) using a structure estimation method(1). This corresponds to an atmospheric half-life of about 4.1 hours at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1). 2-Methylimidazole is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(2).
安全データ
- wgk
- 2
- tsca
- TSCA listed
- rtecs
- NI7175000
- ridadr
- UN 3259 8/PG 2
- 毒性
- LD50 orally in Rabbit: 1500 mg/kg
- hs_code
- 29332990
- risk_code
- 22-34
- 化審法
- (5)-382
- hazard_code
- C
- hazard_note
- Harmful/Corrosive
- safety_code
- 26-36/37/39-45-25
- hazard_class
- 8
- packing_group
- III
- 自然発火温度
- >600 °C DIN 51794
- Hazard Classifications
- Acute Tox. 4 OralCarc. 2Eye Dam. 1Repr. 1BSkin Corr. 1C
- ストレージクラス
- 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
- 有毒物質データの
- 693-98-1(Hazardous Substances Data)
化学と産業
薬理情報
Biological Half-Life
The toxicokinetics of 2-methylimidazole (2-MI) were studied in male and female Fischer 344 rats after a single iv dose of 10 mg/kg or gavage dose of 25, 50, or 100 mg/kg. The 2-MI was formulated in 0.05 M phosphate-buffered saline (pH 7.4) ... The estimated half-life value for 2-MI was about 1 hr for the iv group and the male 25-, 50-, or 100-mg/kg groups and female 25-mg/kg groups ...
Absorption, Distribution and Excretion
... The disposition of [2-(14)C]-2-methylimidazole (2-MI) has been investigated following po administration of either 5, 50, or 150 mg/kg to male F344 rats. Excretion data indicated that absorption of 2-MI was both rapid and proportional to dose in the range studied. Approximately 90% of the total dose was eliminated in urine within 24 hr. Most of the remaining 14C was excreted in feces and as expired 14CO2. Excretion data were similar following iv administration of 5 mg/kg. Little or no enterohepatic circulation of compound occurred, since biliary excretion of 2-MI-derived 14C was negligible. Approximately 70% of the 14C excreted in urine, following all dosing, consisted of parent compound. High-performance liquid chromatography (HPLC) chromatograms for all treatment groups were similar, indicating that metabolism of 2-MI in rats was not affected by dose or route of administration.
The toxicokinetics of 2-methylimidazole (2-MI) were studied in male and female Fischer 344 rats after a single iv dose of 10 mg/kg or gavage dose of 25, 50, or 100 mg/kg. The 2-MI was formulated in 0.05 M phosphate-buffered saline (pH 7.4). The iv profiles could be best described by a two-compartment model with first-order elimination. The terminal elimination half-life, volume of distribution at steady state, and clearance values were 0.78 and 0.85/hr, 1.5 and 1.9 L, and 4.97 and 12.0 L/hr/kg for males and females, respectively. After a gavage dose, the plasma concentration time profiles could be best described by a one-compartment model, no lag phase, and first-order absorption and elimination. The peak 2-MI plasma concentrations increased proportionately with dose and were reached within 35 to 50 min (T(max)) for all groups. The estimated half-life value for 2-MI was about 1 hr for the iv group and the male 25-, 50-, or 100-mg/kg groups and female 25-mg/kg groups. Clearance increased for the male 100- and female 50- and 100- mg/kg groups. For a given dose group, clearance was also two to three times greater for female rats when compared to male rats. Absolute bioavailability for 2-MI was estimated to approach 97%. The results of this study indicated that 2-MI was (1) rapidly and completely absorbed, (2) quickly eliminated, (3) cleared differently for females than for males, (4) affected somewhat by dose for females, and (5) unlikely to undergo tissue accumulation following repeated exposure.
用途と製造
Uses
Used to make pharmaceuticals, photographic and photothermographic chemicals, dyes, pigments, agricultural chemicals, and rubber; Also used in epoxy resin systems for semiconductor potting compounds and soldering masks, as dyeing auxiliary for acrylic fibers and plastic foams, and in polymers such as epoxy resin pastes and acrylic rubber-fluororubber; [HSDB] Present in caramel coloring, tobacco smoke, wine, soy sauce, and other foods; Also formed when ammonia is added to livestock feed to increase nutritional value; Used in various polymers including acrylic rubber-fluororubber laminates, films, adhesives, textile finishes, and epoxy silane coatings; [NTP]
Semiconductor Manufacturing [Category: Industry]
Dyeing auxiliary for acrylic fibers, plastic foams
Used in the manufacture of pharmaceuticals, photographic and photothermographic chemicals, dyes, pigments, agricultural chemicals and rubber; Used in epoxy resin systems for semiconductor potting compounds and soldering masks; Component of polymers including epoxy resin pastes, acrylic rubber-fluororubber
U.S. Production
2023: 50,000 - <75,000 lb
Production volumes for non-confidential chemicals reported under the Inventory Update Rule. [Table#7424]
Methods of Manufacturing
In the generally applicable Radziszewski reaction, a 1,2-dicarbonyl compound is condensed with an aldehyde and ammonia (R1 = H) in a molar ratio of 1:1:2, respectively. Replacement of a molar equivalent of ammonia with a primary amine (R1 = alkyl or aryl) leads to the corresponding 1-substituted imidazoles. The reaction is usually carried out in water or a water-alcohol mixture at 50 - 100 °C. Work-up may involve the usual processes (e.g., distillation, extraction, and crystallization). Distillation leads to imidazole with a purity > 99%. The yield is generally 60 - 85 %. ... Compounds used to prepare simple imidazoles by the Radziszewski reaction: Imidazole: 2-methylimidazole; Dicarbonyl compound: glyoxal; Aldehyde: acetaldehyde; Amine: ammonia.
General Manufacturing Information
Paint and Coating Manufacturing
1H-Imidazole, 2-methyl-: ACTIVE
応用分野
用途主たる用途は医薬品?写真用化学品の合成用の主発材料や中間体である。
使用2-Methylimidazole is a monomethylated imidazole that can be used as a building block in the preparation of a wide range of biologically active compounds. 2-Methylimidazole as well as other imidazoles can be use as catalyst for refolding of enhanced coloured fluorescent protein. 2-Methylimidazole has been identified as a byproduct of fermentation and is detected in foods and mainstream and side-str eam tobacco smoke.
一般的な説明It is a white or colorless solid that is highly soluble in polar organic solvents and water. It is a precursor to a range of drugs and is a ligand in coordination chemistry.
調製方法
純化方法Recrystallise 2-methylimidazole from *benzene or pet ether. The picrate has m 215o (from H2O). [Beilstein 23 III/IV 594, 23/5 V 35.]
上流・下流製品情報
上流原料
下流製品
サプライヤー50 社
関連反応
関連ノート
読み込み中…